Malte Greune, Dr.
Chief Operating Officer
Dr. Malte Greune joined CureVac in 2021 from Sanofi Germany where he held various management positions for almost ten years. As General Manager and Vice President Cartridges, Devices & Insulin Technology Group he was responsible for several manufacturing sites – including Site Frankfurt Biologics & Oncology. Under his oversight, many isolator filling and device assembly lines for insulins, oncological and immunological drugs as well as COVID-19 vaccine were set up and 12 global products were launched.
Prior to his position as Head of Diabetes, Oncology and Devices at Sanofi, he worked as Senior Vice President of Animal Health Manufacturing for the Merck Manufacturing Division, USA, where he led an international network of 28 sites – including 18 integrated vaccine sites. Furthermore, he held various leadership roles at the pharmaceutical companies Schering-Plough and Intervet International. Dr. Greune started his career at Hoechst AG in Corporate Planning.
Dr. Malte Greune received his doctoral degree in the field of Economics from the University of Cologne, Germany, graduated from the University of Trier, Germany, and completed a Master of Business Administration at Clark University in Worcester, USA.